Overview
GHRP-2 (Growth Hormone Releasing Peptide-2) is a hexapeptide that potently stimulates growth hormone release through the ghrelin receptor. It produces one of the strongest GH pulses of the secretagogue family — but the strength comes with trade-offs.
It sits between ipamorelin (cleanest) and GHRP-6 (strongest hunger) in the classic GHRP lineup.
How It Works
GHRP-2 activates GHS-R1a receptors on pituitary somatotrophs and in the hypothalamus, triggering a robust GH pulse and amplifying the natural GHRH signal. It also suppresses somatostatin, the brake on GH release.
The off-target cost
Unlike ipamorelin, GHRP-2 meaningfully raises cortisol and prolactin at higher doses, and stimulates appetite moderately. These effects are dose-dependent and the reason many users eventually migrate to ipamorelin for long-term use.
Key Benefits
Strong GH pulse — among the most potent secretagogues per microgram.
Recovery and sleep — the standard benefits of elevated nocturnal GH.
Body composition — gradual fat loss and lean mass support over months.
Moderate appetite stimulation — a benefit for those struggling to eat enough, a drawback for dieters.
Side Effects & Considerations
Expect increased hunger, possible water retention, and transient tiredness after injection. The cortisol and prolactin elevations are the main differentiators from ipamorelin — chronically elevated prolactin is undesirable for libido and mood.
Practical position
GHRP-2 is a reasonable short-cycle choice when a strong pulse is the goal, but most experienced users reserve it for that role and default to ipamorelin otherwise. Not approved for human use, WADA prohibited, and subject to the usual grey-market quality lottery.
Dosage protocols
| Protocol | Dosage | Frequency | Duration | Notes |
|---|---|---|---|---|
| Standard (anecdotal) | 100-300 mcg | 2-3 times daily | 8-12 weeks | Inject fasted; carbohydrates blunt the pulse. Bedtime dose maximizes nocturnal GH. |
Warnings
Raises cortisol and prolactin at higher doses. Not approved for human use. WADA prohibited.